• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Biol . A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets

tetano

Editor, Senior Moderator
PLoS Biol


. 2021 Dec 28;19(12):e3001490.
doi: 10.1371/journal.pbio.3001490. Online ahead of print.
A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets


Annika Kratzel[SUP] 1 2 3 [/SUP], Jenna N Kelly[SUP] 1 2 4 [/SUP], Philip V'kovski[SUP] 1 2 [/SUP], Jasmine Portmann[SUP] 1 2 [/SUP], Yannick Brüggemann[SUP] 5 [/SUP], Daniel Todt[SUP] 4 5 [/SUP], Nadine Ebert[SUP] 1 2 [/SUP], Neeta Shrestha[SUP] 6 [/SUP], Philippe Plattet[SUP] 6 [/SUP], Claudia A Staab-Weijnitz[SUP] 7 [/SUP], Albrecht von Brunn[SUP] 8 9 [/SUP], Eike Steinmann[SUP] 5 [/SUP], Ronald Dijkman[SUP] 1 2 4 10 [/SUP], Gert Zimmer[SUP] 1 2 [/SUP], Stephanie Pfaender[SUP] 5 [/SUP], Volker Thiel[SUP] 1 2 [/SUP]



Affiliations

Abstract

Over the past 20 years, 3 highly pathogenic human coronaviruses (HCoVs) have emerged-Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and, most recently, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-demonstrating that coronaviruses (CoVs) pose a serious threat to human health and highlighting the importance of developing effective therapies against them. Similar to other viruses, CoVs are dependent on host factors for their survival and replication. We hypothesized that evolutionarily distinct CoVs may exploit similar host factors and pathways to support their replication cycles. Herein, we conducted 2 independent genome-wide CRISPR/Cas-9 knockout (KO) screens to identify MERS-CoV and HCoV-229E host dependency factors (HDFs) required for HCoV replication in the human Huh7 cell line. Top scoring genes were further validated and assessed in the context of MERS-CoV and HCoV-229E infection as well as SARS-CoV and SARS-CoV-2 infection. Strikingly, we found that several autophagy-related genes, including TMEM41B, MINAR1, and the immunophilin FKBP8, were common host factors required for pan-CoV replication. Importantly, inhibition of the immunophilin protein family with the compounds cyclosporine A, and the nonimmunosuppressive derivative alisporivir, resulted in dose-dependent inhibition of CoV replication in primary human nasal epithelial cell cultures, which recapitulate the natural site of virus replication. Overall, we identified host factors that are crucial for CoV replication and demonstrated that these factors constitute potential targets for therapeutic intervention by clinically approved drugs.
 
Back
Top Bottom